The VALTIVE1 study protocol: a study for the validation of Tie2 as the first tumour vascular response biomarker for VEGF inhibitors. Carucci M, Clamp A, Zhou C, Hurt C, et al. BMC Cancer 2024;24:1309.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Carucci M, Clamp A, Zhou C, Hurt C, et al. The VALTIVE1 study protocol: a study for the validation of Tie2 as the first tumour vascular response biomarker for VEGF inhibitors. BMC Cancer 2024;24:1309.
PMID: 39448911